306 related articles for article (PubMed ID: 37521793)
21. Purity by design: Reducing impurities in bioproduction by stimulus-controlled global translational downregulation of non-product proteins.
Bojar D; Fuhrer T; Fussenegger M
Metab Eng; 2019 Mar; 52():110-123. PubMed ID: 30468874
[TBL] [Abstract][Full Text] [Related]
22. Bifunctional modalities for repurposing protein function.
Modell AE; Lai S; Nguyen TM; Choudhary A
Cell Chem Biol; 2021 Jul; 28(7):1081-1089. PubMed ID: 34270935
[TBL] [Abstract][Full Text] [Related]
23. ProxyBind: A compendium of binding sites for proximity-induced pharmacology.
Rovers E; Liu L; Schapira M
Comput Struct Biotechnol J; 2022; 20():6163-6171. PubMed ID: 36420167
[TBL] [Abstract][Full Text] [Related]
24. Molecular Spatiomics by Proximity Labeling.
Kang MG; Rhee HW
Acc Chem Res; 2022 May; 55(10):1411-1422. PubMed ID: 35512328
[TBL] [Abstract][Full Text] [Related]
25. Reactivity-Based Organic Theranostic Bioprobes.
Kenry ; Chong KC; Liu B
Acc Chem Res; 2019 Nov; 52(11):3051-3063. PubMed ID: 31588730
[TBL] [Abstract][Full Text] [Related]
26. Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.
Galdeano C; Ciulli A
Future Med Chem; 2016 Sep; 8(13):1655-80. PubMed ID: 27193077
[TBL] [Abstract][Full Text] [Related]
27. Engineered cell-based therapies: a vanguard of design-driven medicine.
Dudek RM; Chuang Y; Leonard JN
Adv Exp Med Biol; 2014; 844():369-91. PubMed ID: 25480651
[TBL] [Abstract][Full Text] [Related]
28. Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders.
Ishoey M; Chorn S; Singh N; Jaeger MG; Brand M; Paulk J; Bauer S; Erb MA; Parapatics K; Müller AC; Bennett KL; Ecker GF; Bradner JE; Winter GE
ACS Chem Biol; 2018 Mar; 13(3):553-560. PubMed ID: 29356495
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs.
Rittiner J; Cumaran M; Malhotra S; Kantor B
Front Bioeng Biotechnol; 2022; 10():1035543. PubMed ID: 36324900
[TBL] [Abstract][Full Text] [Related]
30. Branched immunochip-integrated pairwise barcoding amplification exploring the spatial proximity of two post-translational modifications in distinct cell subpopulations.
Xue J; Fu Y; Fan S; Cao X; Huang W; Zhang J; Zhao Y; Chen F
Chem Commun (Camb); 2022 Sep; 58(72):10020-10023. PubMed ID: 35983894
[TBL] [Abstract][Full Text] [Related]
31. Drug Hunting at the Nexus of Medicinal Chemistry and Chemical Biology and the Discovery of Novel Therapeutic Modalities.
Palacios DS
J Med Chem; 2022 Oct; 65(20):13594-13613. PubMed ID: 36206538
[TBL] [Abstract][Full Text] [Related]
32. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
33. Mutual leveraging of proximity effects and click chemistry in chemical biology.
Dong R; Yang X; Wang B; Ji X
Med Res Rev; 2023 Mar; 43(2):319-342. PubMed ID: 36177531
[TBL] [Abstract][Full Text] [Related]
34. Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine.
Blokzijl A; Friedman M; Pontén F; Landegren U
J Intern Med; 2010 Sep; 268(3):232-45. PubMed ID: 20695973
[TBL] [Abstract][Full Text] [Related]
35. Grand challenges in space synthetic biology.
Menezes AA; Montague MG; Cumbers J; Hogan JA; Arkin AP
J R Soc Interface; 2015 Dec; 12(113):20150803. PubMed ID: 26631337
[TBL] [Abstract][Full Text] [Related]
36. Phenotype and target-based chemical biology investigations in cancers.
Chen GQ; Xu Y; Shen SM; Zhang J
Natl Sci Rev; 2019 Nov; 6(6):1111-1127. PubMed ID: 34691990
[TBL] [Abstract][Full Text] [Related]
37. [Cell-free synthetic biology: an emerging strategy torevolutionize the biomedical industry].
Liu Y; Bu N; Lu Y
Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2269-2283. PubMed ID: 31880135
[TBL] [Abstract][Full Text] [Related]
38. Haven't got a glue: Protein surface variation for the design of molecular glue degraders.
Kozicka Z; Thomä NH
Cell Chem Biol; 2021 Jul; 28(7):1032-1047. PubMed ID: 33930325
[TBL] [Abstract][Full Text] [Related]
39. Protein Crotonylation Expert Review: A New Lens to Take Post-Translational Modifications and Cell Biology to New Heights.
Subba P; Prasad TSK
OMICS; 2021 Oct; 25(10):617-625. PubMed ID: 34582706
[TBL] [Abstract][Full Text] [Related]
40. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
